These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26618182)

  • 1. Innate-Adaptive Immune Crosstalk.
    Shanker A; Thounaojam MC; Mishra MK; Dikov MM; Uzhachenko RV
    J Immunol Res; 2015; 2015():982465. PubMed ID: 26618182
    [No Abstract]   [Full Text] [Related]  

  • 2. Innate-Adaptive Immune Crosstalk 2016.
    Shanker A; Thounaojam MC; Mishra MK; Dikov MM
    J Immunol Res; 2017; 2017():3503207. PubMed ID: 28491874
    [No Abstract]   [Full Text] [Related]  

  • 3. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
    Mahmood S; Upreti D; Sow I; Amari A; Nandagopal S; Kung SK
    Immunotherapy; 2015; 7(3):301-8. PubMed ID: 25804481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new avenue to cure cancer by turning adaptive immune T cells to innate immune NK cells via reprogramming.
    Su DM; Vankayalapati R
    J Mol Cell Biol; 2010 Oct; 2(5):237-9. PubMed ID: 20693167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunity and immunosuppression in tumor growth].
    Govallo VI
    Vopr Onkol; 1987; 33(4):91-9. PubMed ID: 3296437
    [No Abstract]   [Full Text] [Related]  

  • 6. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity.
    Münz C; Steinman RM; Fujii S
    J Exp Med; 2005 Jul; 202(2):203-7. PubMed ID: 16027234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-resident and memory properties of human T-cell and NK-cell subsets.
    Lugli E; Hudspeth K; Roberto A; Mavilio D
    Eur J Immunol; 2016 Aug; 46(8):1809-17. PubMed ID: 27431095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer cells and T lymphocytes in pregnancy and pre-eclampsia.
    Taylor EB; Sasser JM
    Clin Sci (Lond); 2017 Dec; 131(24):2911-2917. PubMed ID: 29222389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell-based cancer immunotherapy: from basic biology to clinical application.
    Li Y; Yin J; Li T; Huang S; Yan H; Leavenworth J; Wang X
    Sci China Life Sci; 2015 Dec; 58(12):1233-45. PubMed ID: 26588912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of cigarette smoking on immune responsiveness: Up and down or upside down?
    Qiu F; Liang CL; Liu H; Zeng YQ; Hou S; Huang S; Lai X; Dai Z
    Oncotarget; 2017 Jan; 8(1):268-284. PubMed ID: 27902485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasuppression, class I antigens, and cancer immunity.
    Green DR; Gershon RK
    Haematol Blood Transfus; 1983; 28():479-85. PubMed ID: 6602750
    [No Abstract]   [Full Text] [Related]  

  • 12. The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells.
    Narni-Mancinelli E; Vivier E; Kerdiles YM
    Int Immunol; 2011 Jul; 23(7):427-31. PubMed ID: 21665959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune mediators in cancer: between defense and resistance.
    Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
    Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for innate immunity and CD90⁺ NK1.1⁻ lymphocytes to treat established melanoma with chemo-immunotherapy.
    Moskalenko M; Pan M; Fu Y; de Moll EH; Hashimoto D; Mortha A; Leboeuf M; Jayaraman P; Bernardo S; Sikora AG; Wolchok J; Bhardwaj N; Merad M; Saenger Y
    Cancer Immunol Res; 2015 Mar; 3(3):296-304. PubMed ID: 25600438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural killer cells: adaptation and memory in innate immunity].
    Narni-Mancinelli E; Ugolini S; Vivier E
    Med Sci (Paris); 2013 Apr; 29(4):389-95. PubMed ID: 23621934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-15: targeting CD8+ T cells for immunotherapy.
    Diab A; Cohen AD; Alpdogan O; Perales MA
    Cytotherapy; 2005; 7(1):23-35. PubMed ID: 16040381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.
    Zhu EF; Gai SA; Opel CF; Kwan BH; Surana R; Mihm MC; Kauke MJ; Moynihan KD; Angelini A; Williams RT; Stephan MT; Kim JS; Yaffe MB; Irvine DJ; Weiner LM; Dranoff G; Wittrup KD
    Cancer Cell; 2015 Apr; 27(4):489-501. PubMed ID: 25873172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate immune memory: towards a better understanding of host defense mechanisms.
    Quintin J; Cheng SC; van der Meer JW; Netea MG
    Curr Opin Immunol; 2014 Aug; 29():1-7. PubMed ID: 24637148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacillus Calmette-Guérin as an anti-tumor agent. The interaction with cells of the mammalian immune system.
    Davies M
    Biochim Biophys Acta; 1982 Apr; 651(2-3):143-74. PubMed ID: 7046801
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.
    Wallace ME; Smyth MJ
    Springer Semin Immunopathol; 2005 Jun; 27(1):49-64. PubMed ID: 15729567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.